Lisa Tan

Statistics

Publications

Citations

612

H-Index

Active since

2016

Affiliations

Apellis Pharmaceuticals (United States)(Current)

Duke University

RWTH Aachen University

St James's University Hospital

Prince of Wales Hospital

Lisa Tan is an author at Apellis Pharmaceuticals (United States) specializing in clinical pharmacology, paroxysmal nocturnal hemoglobinuria therapy, and hemolytic disorders.

Publications per year

2016–2024

Publications

Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Jeff Szer, Ilene C. Weitz et al. · New England Journal of Medicine · 2021 · 385 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

<scp>C3</scp> inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab

Carlos de Castro, F Grossi, Ilene C. Weitz et al. · American Journal of Hematology · 2020 · 98 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Inhibition of C3 with pegcetacoplan results in normalization of hemolysis markers in paroxysmal nocturnal hemoglobinuria

Raymond Wong, Humphrey Pullon, Ismail Amine et al. · Annals of Hematology · 2022 · 39 citations · Full text

Medicine, Hematology, Pharmacology +15

APL-2, a Complement C3 Inhibitor for the Potential Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH): Phase I Data from Two Completed Studies in Healthy Volunteers

F Grossi, Pauline Bedwell, Pascal Deschatelets et al. · Blood · 2016 · 32 citations

Medicine, Hematology, Pharmacology +11

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Raymond Wong, Humphrey Pullon, Pascal Deschatelets et al. · Blood · 2018 · 23 citations

Medicine, Hematology, Pharmacology +16

1–5 of 7